Amgen Inc vs. Armata Pharmaceuticals, Inc. Common Stock
Amgen Inc and Armata Pharmaceuticals, Inc. Common Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| AMGN | ARMP | |
|---|---|---|
| Market Cap | $226.88 billion | $166.58 million |
| Revenue (TTM) | $38.09 billion | — |
| Net Income (TTM) | $8.74 billion | — |
AMGN leads on 1 of 1 size & scale factors.
Valuation
| AMGN | ARMP | |
|---|---|---|
| P/E Ratio | 27.22 | — |
| Price / Book | 19.41 | — |
| Price / Sales | 5.96 | — |
AMGN and ARMP split the valuation factors evenly.
Profitability
| AMGN | ARMP | |
|---|---|---|
| Net Margin | 22.95% | — |
| Return on Equity | 74.80% | — |
AMGN and ARMP split the profitability factors evenly.
Dividend
| AMGN | ARMP | |
|---|---|---|
| Dividend Yield | 2.30% | — |
| Payout Ratio | 62.61 | — |
AMGN and ARMP split the dividend factors evenly.
Risk & Sentiment
| AMGN | ARMP | |
|---|---|---|
| Short Interest | 1.66% | 0.37% |
ARMP leads on 1 of 1 risk & sentiment factors.
Dig deeper: AMGN overview, AMGN financials, ARMP overview, ARMP financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.